Our website uses cookies to provide your browsing experience and relevant information. Before continuing to use our website, you agree & accept our Cookie Policy & Privacy.

A skin cancer vaccine was tested in the U.S. — how much did it reduce the risk of recurrence?

unn.ua

A skin cancer vaccine was tested in the U.S. — how much did it reduce the risk of recurrence?

A skin cancer vaccine was tested in the U.S. — how much did it reduce the risk of recurrence?A vaccine created based on tumor mutations, combined with Keytruda, reduced the risk of melanoma recurrence by 42%. The drug isstill experimental.
  • Last
More news

News by day

Today,
24 of October 2026

Related news

More news